Literature DB >> 3456298

Silico-acrylate contact lenses for extended wear.

J H Kok, W H Beekhuis, H van Nes.   

Abstract

Extended wear contact lenses (EWCL) have been successfully used for the correction of aphakia. Disadvantages of soft EWCL are lens precipitates, lens loss and failure to correct higher astigmatic errors. Silico-acrylate rigid EWCL with high oxygen transmissibility have been used in this study to correct aphakia and higher astigmatic errors. Fourteen eyes were fitted with Boston IV lenses and observed for a mean of 6.5 months. All patients tolerated the rigid EWCL well without important complications. One patient discontinued lens wear because of discomfort without obvious clinical abnormalities. Rigid silico-acrylate EWCL are a reliable alternative for soft EWCL and are in some cases to be preferred to soft EWCL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456298     DOI: 10.1007/BF00142358

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  6 in total

1.  Oxygen tension under a soft or hard, gas-permeable contact lens in the presence of tear pumping.

Authors:  I Fatt; D Lin
Journal:  Am J Optom Physiol Opt       Date:  1976-03

2.  Oxygen tension distributions in the cornea: a re-examination.

Authors:  I Fatt; R D Freeman; D Lin
Journal:  Exp Eye Res       Date:  1974-04       Impact factor: 3.467

3.  Critical oxygen tension at the corneal surface.

Authors:  K A Polse; R B Mandell
Journal:  Arch Ophthalmol       Date:  1970-10

4.  Extended-wear Hydrocurve and Sauflon contact lenses.

Authors:  P S Binder; C Woodward
Journal:  Am J Ophthalmol       Date:  1980-09       Impact factor: 5.258

5.  Corneal response to rigid and hydrogel lenses during eye closure.

Authors:  M R O'Neal; K A Polse; M D Sarver
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-07       Impact factor: 4.799

6.  Corneal swelling at low atmospheric oxygen pressures.

Authors:  R B Mandell; R Farrell
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-06       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.